Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Cascadia Commences First Drill Test of 1,065 g/t Gold Outcrop at Catch Property (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Recursion Pharmaceuticals Inc
RXRX
Healthcare
Biotechnology
Recursion Pharmaceuticals, Inc. is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components...
as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology include REC-617, REC-1245, REC-3565 and REC-4539. Its clinical programs in rare diseases include REC-994, REC-4881, REC-2282, and REC-3964. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RXRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 14, 2025 5:59am
Buy buddy buy.
Otherwise you guys will be missing out on this one
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 11, 2025 6:35am
Buy buddy buy because it's taking off this morning.
It is signalling a big upswing for this stock today
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 31, 2025 7:57am
Sell buddy sell.
Otherwise you guys out there will be going down today big-time with this stock already
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 18, 2025 8:00am
New Press Release - Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun
Dr. Bumpus brings deep experience in scientific innovation and regulatory strategy, while Elaine Sun adds extensive leadership in life sciences finance and corporate strategy. Salt Lake City, UT, March 18, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 28, 2025 6:30am
New Press Release - Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and demonstrated encouraging trends in efficacy for REC-994 in cerebral cavernous malformationsAdvanced three new clinical studies across oncology, rare disease, and recurrent C....
read article.
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 24, 2025 8:02am
Still holding this stock.
It is signalling strength to the upside this morning,so good luck to all
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 24, 2025 8:00am
New Press Release - Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th
Company to host public (L)earnings call on February 28th at 8:30 am ET / 6:30 am MT / 1:30 pm GMT Salt Lake City, UT, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 19, 2025 9:00am
New Press Release - Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City
The Altitude Lab Fund aims to deliver strong returns to Limited Partners, accelerate the growth of Salt Lake City’s Life Science hub, and enable high potential startups support while federal funding is stalled SALT LAKE CITY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Altitude Lab, a biotech accelerator...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 18, 2025 11:00am
New Press Release - Altitude Lab Startups Raise $154M in Capital
The Accelerator Awards $150,000 Fellowship to Elnora AI CEO, and Announces Key Cohort Milestones SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Today, Altitude Lab announced that its incubating startups have collectively raised $154 million in early-stage funding since its launch in 2020...
read article.
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 18, 2025 7:45am
Buy buddy buy.
Otherwise you guys out there will be missing out big-time.
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 14, 2025 11:04am
Using technical analysis for this one.
This stock is looking really good here for shareholders
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 14, 2025 5:24am
Buy buddy buy because it's taking off this morning.
So that you fellas should be on-board with this one already.
(38)
•••
Humanist
X
Post by
Humanist
on Feb 12, 2025 8:34pm
RXRX: files for mixed shelf ! Size not disclosed
BRIEF-Recursion Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing Recursion Pharmaceuticals Inc: * RECURSION
...more
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 06, 2025 9:31am
This stock is still cheap.
It was a big stroke of luck for me to get on-board with it.
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 06, 2025 7:51am
Buy buddy buy.Wow.
It's only the beginning of a big uptrend for this stock.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >